CClinicalTrials.gg
RecruitingNCT07272577Updated Dec 11, 2025

Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries

An interventional study of Erector spinae plane block in Erector Spinae Plane Block, Postoperative Analgesia and Laparoscopic Abdominal Surgeries, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-11.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Dec 2025; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the efficacy of the erector spinae plane block (ESPB) on postoperative analgesia in patients undergoing laparoscopic abdominal surgeries.

Read the detailed description

Laparoscopic surgery is associated with less pain, fewer wound infections, reduced hospital stay, reduced morbidity and mortality, and early return to work and improved overall quality of life.

The role of ESPB as a better analgesic modality in reducing 24-hour opioid consumption has recently been established for post-operative analgesia in breast surgeries, video-assisted thoracoscopic surgery, and cardiothoracic surgeries.

02

Conditions studied

  • Erector Spinae Plane Block
  • Postoperative Analgesia
  • Laparoscopic Abdominal Surgeries
03

In context

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I-II.
  • Body mass index (BMI) between 20-30 kg/m2.
  • Patients undergoing laparoscopic abdominal surgeries under general anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Bleeding or coagulation disorders.
  • Having local sepsis, pre-existing.
  • Peripheral neuropathies.
  • Chronic pain conditions.
  • Having any contraindication to regional anesthesia administration.
  • Opioid dependency.
  • Hypertension.
  • Uncontrolled diabetes mellitus.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Erector spinae plane block group

    Patients will receive an ultrasound-guided erector spinae plane block.

    Other: Erector spinae plane block

  • No intervention
    Control group

    The block will not be performed, and the patients will be shifted to the operation room.

Interventions

  • OtherErector spinae plane block

    Patients will receive an ultrasound-guided erector spinae plane block.

06

What researchers measure

Primary outcomes

  1. Time to the 1st rescue analgesia

    Time to the first request for the rescue analgesia (time from the end of surgery to first dose of morphine administrated).

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. Total morphine consumption

    Rescue analgesia of morphine will be given as 3 mg bolus if the Visual Analogue Scale (VAS) \> 3 to be repeated after 30 min if pain persists until the VAS \< 4.

    Time frame: 24 hours postoperatively

  2. Mean arterial pressure

    Mean arterial pressure will be recorded before skin incision, one minute after skin incision and then recorded regularly every 10 minutes.

    Time frame: Till the end of surgery (Up to 2 hours)

  3. Heart rate

    Heart rate will be recorded before skin incision, one minute after skin incision and then recorded regularly every 10 minutes.

    Time frame: Till the end of surgery (Up to 2 hours)

  4. Degree of pain

    Each patient will be instructed about postoperative pain assessment with the Visual Analogue Scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed at 0, 4, 6, 8, 12, and 24 h postoperatively.

    Time frame: 24 hours postoperatively

  5. Incidence of adverse events

    Incidence of adverse events such as bradycardia, hypotension, nausea, vomiting, respiratory depression, or any other complication were recorded.

    Time frame: 24 hours postoperatively

07

Study locations

1 of 1 sites recruiting
  • Assiut University
    Asyut, 71515, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07272577
Lead sponsor
Assiut University
Responsible party
Bahaa Gamal Saad Mohamed (Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt., Assiut University) — Principal investigator
First posted
Dec 9, 2025
Start date
Dec 10, 2025
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Dec 11, 2025

Study contacts

Bahaa G Saad, MD
Contact
bahaagamal@aun.edu.eg
00201555590977

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion